sp
issue
trans
million
taken
recruitment
london
alleles
potentially
medicine
conclusions
shown
declared
trust
previous
hematologically
vulliamy
prince
steadily
studied
sulphonamides
access
ruwende
confer
contributions
activity
presence
rbm
thank
fasuan
sided
alessandro5
luzzatto
2002
death
characterized
nature
there
metzger
regardless
market
thailand
cord
appropriate
rate
180
246
south
density
prolongation
sensitivity
people
provides
quinine
conditions
treated
source
protection
acquisition
falciparum
outcome
occur
info
0001
marked
506
whom
authors
hydrochloride
001
even
characterised
african
1991
exacerbated
artemether
calculated
homozy
intervals
restriction
serious
genotyped
final
poor
iea
therapies
phosphate
orion
treatments
clinical
mediterranean
htm
danger
137
pressreleases
diversity
diagnosed
rome
drugs
known
approximately
differences
191
additional
sd
position
005
director
lowest
varies
mmol
kingdom
t003
table
g001
line
inpatient
sulphone
exposure
fisher
result
val68met
registration
360
references
findings
microhae
gov
plus
detail
fanello
gdb
david
pone
constructively
ctg
need
white
or
could
does
foods
per
validated
performed
susceptible
process
whereas
families
explanatory
1843
sanofi
cv
research
young
predominates
battistuzzi
powered
gel
haematocrit
uninfect
amplification
both
program
applicable
although
male
uwimana2
important
ck
samples
trop
rev
175
aca
comparison
convulsions
girl
all
microsoft
biomalpar
aline
located
abbes
26018
648
2006
would
administered
rb
chimpeni
primer
inherited
red
significantly
ratios
202
total
development
412
avellino3
parasite
kigali
including
control
sue
pamela
sciences
wr
kanjala
202gra
supportive
malaria
hours
kenya
karema
299
disease
paediatric
mgcl2
lshp
eppes
bancone
below
during
academic
annealing
ministry
efficacy
cases
self
elsewhere
temporary
amplified
cape
methods
drink
recently
saf
grateful
prophylaxis
haplotype
age
158
decreasing
aaa
fetal
volume
higher
wallis
distributed
results
004
antimalarial
cif
hrs
relative
contract
attribution
appear
open
worker
significant
axillary
ndm
geometric
area
metaphor
exist
preliminary
duparc
40978
attributed
necessary
impaired
protecting
165
extraction
post
natural
funding
ud
induced
card
four
they
munyanganizi
heterozygotes
accelerated
cotton
adverse
117
sales
experience
defences
electrophoresis
who
encoding
according
previously
simple
cycle
bwika
filter
staff
pneumonia
multivariate
failure
media
transfusions
factors
commonly
plos
consisting
heterozygous
polymorphisms
pre
dapsone
mail
distinguish
effects
receiving
breastfeed
newly
multi
median
pneumocystic
oxidant
life
tested
subject
uwimana
6sd
activities
author
chi
she
exact
chlorproguanil
college
recovery
139
model
129
national
stand
sulfadoxine
risk
brand
remaining
explain
identified
poorly
beginning
software
permits
whatman
modiano
patient
measured
presented
study
recycling
arm
milder
rl
populations
outcomes
committees
342
visit
case
72uc
alone
combination
oxidants
bioline
about
recipients
models
sites
metabolite
120
taylor
defined
tj
relation
kruskal
nebiolabs
log
together
girls
original
seldom
increase
pharmacy
soc
continuous
1143
mal
normal
200
ta
destroyed
doi
dosage
acg
2001
published
monitoring
continent
exited
possible
months
widely
squared
gb
beutler
station
online
length
containing
verhoeff
mentioning
protective
neonates
fractional
competing
deficient
glucose
parametric
evident
random
proportions
manifestations
erythrocytes
excluding
under
hygiene
t004
prevalence
molecular
our
its
differential
sjl
determined
med
462
signs
collection
pyrimethamine
group
incapacity
eu
home
ine
cycles
provided
modiano3
demography
toxicity
accepted
293
322
dyserythropoeisis
medical
cc
soon
origin
vomiting
end
treatment
baker
damage
funded
354
hospitalized
commons
failures
classified
hyg
without
than
measure
initial
clinicaltrials
monitored
19697
department
transfusing
pregnancy
presentation
history
fit
reduction
digested
follow
rapid
sulo
concentration
cells
resistance
comparable
cdc
baseline
following
data
prof
131
hum
whose
corresponding
degowin
after
discussion
amodiaquine
cd
195
2005
collaboration
sulphadoxine
versus
difference
allocated
disability
span
belgium
eds
reported
fall
174
dntps
randomised
assessment
recruited
demographic
mahidol
188
sodes
nigeria
whole
conducted
centre
linkage
org
mk
chlor
whether
e4031
pro
three
hemizygous
sapienza
respectively
needed
develop
vaccinology
min
differs
was
experienced
unconsciousness
two
lethargy
376
count
each
brabin
karema2
africa
regions
role
hydroxylamine
reductase
variable
assess
bone
germana
accordingly
occurrence
0004031
atc
vulnerable
haemoglobin
profile
resulted
tropical
qsm
weight
leprosy
countries
sn
transfused
chromosomal
available
revising
sulphadox
antwerp
approved
asn126asp
however
sc
double
italy
179
patients
compared
nuffield
tac
one
combinations
did
extensive
estimated
method
gsk
tration
decision
any
more
credited
material
subjects
usa
mutation
groups
laboratory
among
plustm
considered
threatening
wbc
most
analyse
had
steeper
carson
acknowledgments
tropics
dermatology
proportion
sequential
alloueche
asexual
again
genotype
still
ct
ga
maternal
phase
skin
fa
parasitaemia
biagini
remarkably
average
doctor
iii
network
fact
nick
25162
variant
cause
drug
only
infection
genotyping
odds
glaxosmithk
status
enzyme
requiring
advances
recorded
blind
produced
recall
dgis
avellino
hatcher
analyses
devel
malarial
monly
discontinued
into
seven
weekly
journal
ratio
dependent
221
traced
stopped
recovered
defi
rd
fifteen
sulphones
khoo
stewart
parasitological
corine
t001
numerous
associated
deficiency
tishkoff
phenotypic
carinii
aag
blood
uganda
lapdap
da
preparation
least
ci
less
parasitology
due
consequent
regression
400
powell
collected
analysis
633
introduction
1977
increased
frequent
fixed
independent
paper
received
tx
last
decline
daily
similar
1995
cooperation
evaluated
changes
areas
described
same
precipitated
belgian
science
regeneration
license
rwandan
statacorp
transition
bj
individuals
umberto
affects
doubled
oxidative
secondary
some
biotechniques
lancet
sickle
unrestricted
barton
393
non
given
against
aged
plays
congo
carefully
agranulocytosis
bangkok
19860
separate
label
cahinhinan
bancone3
enzymes
article
between
likely
funders
102
atlanta
163
plosone
1106
5uc
female
dm
influenced
19348
buffer
adjustment
gag
compensation
endemic
acute
levels
variation
higuchi
anaemia
dose
com
trial
multicentre
france
e1779
320
pcv
profiles
249
wolf
140
creative
manifestation
www
adequate
enrolment
controlled
older
public
brentford
diseases
product
fanello1
destruction
1848
children
consider
saharan
day
muller
lysis
stata
230
hemi
univariate
lower
specific
design
characteristics
illness
interests
geneva
using
package
females
single
gabon
males
37uc
reactions
critical
dehydrogenase
formulated
orally
ethics
involved
corrected
other
united
dna
parenteral
normally
363
boys
oxford
university
transfusion
inability
mc
another
rr
2008
entered
properties
sit
clearance
clinically
nj
rwanda
limited
manuscript
plasmodium
manner
completed
biotaq
parise
organ
within
aventis
commercial
genetic
2004
702
leopold
plowe
response
hepatomegaly
sex
matz
well
recent
because
depends
worth
455
61uc
level
opment
followed
concomitant
gender
occurring
bull
faculty
haematological
uk
divided
adminis
frequency
tesunate
barnes
37925
rwandese
pcr
management
yates
world
hospital
guidelines
early
chromosome
equal
18950
ngamije
tuzun
them
used
figure
nor
polymerase
december
press
when
background
categorised
gj
t002
copyright
http
challenge
95uc
may
348
different
789
nlaiii
haemolytic
terms
definitions
denaturation
conduct
bailey
1992
sentinel
further
change
walsh
november
anova
splenomegaly
number
295
fragments
organization
demograph
untoward
called
lapdaptrade
mali
lumefantrine
comparative
institute
causes
dg
ciencies
agc
kublin
population
nct00461578
test
22731
step
sa
resist
100
300
stress
identical
800
event
typing
their
administration
having
financed
included
interpretation
adjusted
vertongen
primers
forensic
proguanil
pathophysiology
carried
required
rw
dds
also
aq
distribution
g6pd
related
translate
but
ps
found
briefly
excellence
argyropoulos
cedex
wootton
enables
prevent
documented
statistical
like
citation
repeated
receive
skewed
include
marrow
suppression
varkonyi
chelex
papers
nearly
low
glutathione
allele
extension
limiting
through
sixth
gcc
gene
allows
worldwide
molecules
sir
based
developed
screening
packed
1371
formal
school
nigerians
513
karen
allelic
matocrit
unit
1136
pe
fell
once
centrifugation
esan
such
greater
heterogeneity
degree
ndahindwa
equivalent
persistent
26808
parasitized
hospitalisation
lee1
decreased
successful
heterozy
june
present
620
successfully
assessed
analysed
programme
kwiatkowski
evaluate
gentilly
version
common
health
human
review
gous
twice
framework
genet
homozygous
nadph
eggelte
general
differentiates
methaemoglobinaemia
pa
nine
cell
five
touchdown
showed
artesunate
largest
28158
has
reaction
disorders
2007
162
etf
defect
out
reticulocytosis
103
thereafter
apart
gulbis
stage
editor
days
publish
missense
tablets
lapdaph
town
lapdaptm
haemolysis
hypersensitivity
contributed
2008_pressrelease_0014
consequence
doses
safety
opara
use
requires
haemo
despite
until
22262
uncomplicated
commenced
temperature
name
779
confidence
epi
therapy
cambrex
1966
mentioned
existing
events
321
792
protocol
ethical
essential
march
contribution
randomized
disequilibrium
idiosyncratic
malawi
observed
420
cda
au
volumes
highest
mean
gda
jg
503578
reproduction
syndrome
along
not
mark
halley
loss
enzymatic
drop
range
inactivation
informed
medium
selection
caterina
particularly
severe
effect
transmission
reduced
remained
declined
times
standard
diaphenylsulfone
mutations
before
southwest
persons
jr
abstract
major
cag
high
combined
first
185
snow
overall
sub
2003